Ind-Swift Laboratories Limited has informed the Exchange regarding 'UPDATE ON LISTING OF SHARES ALLOTTED PURSUANT TO THE SCHEME OF AMALGAMATION'.
INDSWFTLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.8 pts more than Nifty Microcap 250 and 0.2 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Ind-Swift Laboratories Limited is updating stakeholders on the listing status of equity shares allotted to shareholders of Ind-Swift Limited under an approved Scheme of Amalgamation. The shares were allotted on August 25, 2025, and listing applications were filed with NSE and BSE on September 12, 2025. NSE has already granted listing approval on October 10, 2025, while BSE approval is awaited and expected shortly. Once both approvals are received, shares will be credited to shareholders' demat accounts, after which trading approval will be sought. The company is in regular communication with BSE to expedite the process.
Existing shareholders of Ind-Swift Limited should expect the newly allotted shares of Ind-Swift Laboratories to be credited to their demat accounts soon, enabling them to trade once BSE approval and trading permission are obtained. This is a procedural update, not a new business event, so immediate stock price impact is unlikely.